Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1161

1.

Analysis of human and mouse reprogramming of somatic cells to induced pluripotent stem cells. What is in the plate?

Boué S, Paramonov I, Barrero MJ, Izpisúa Belmonte JC.

PLoS One. 2010 Sep 17;5(9). pii: e12664. doi: 10.1371/journal.pone.0012664.

2.

Genome-wide reprogramming in hybrids of somatic cells and embryonic stem cells.

Ambrosi DJ, Tanasijevic B, Kaur A, Obergfell C, O'Neill RJ, Krueger W, Rasmussen TP.

Stem Cells. 2007 May;25(5):1104-13. Epub 2007 Feb 1.

3.

Evolution of induced pluripotent stem cell technology.

Zhou H, Ding S.

Curr Opin Hematol. 2010 Jul;17(4):276-80. doi: 10.1097/MOH.0b013e328339f2ee. Review.

PMID:
20442654
4.

Modulation of chromatin modifying factors' gene expression in embryonic and induced pluripotent stem cells.

Luzzani C, Solari C, Losino N, Ariel W, Romorini L, Bluguermann C, Sevlever G, Barañao L, Miriuka S, Guberman A.

Biochem Biophys Res Commun. 2011 Jul 15;410(4):816-22. doi: 10.1016/j.bbrc.2011.06.070. Epub 2011 Jun 15.

PMID:
21703227
5.

Generation of mice derived from induced pluripotent stem cells.

Boland MJ, Hazen JL, Nazor KL, Rodriguez AR, Martin G, Kupriyanov S, Baldwin KK.

J Vis Exp. 2012 Nov 29;(69):e4003. doi: 10.3791/4003.

6.

Progress made in the reprogramming field: new factors, new strategies and a new outlook.

Hussein SM, Nagy AA.

Curr Opin Genet Dev. 2012 Oct;22(5):435-43. doi: 10.1016/j.gde.2012.08.007. Epub 2012 Sep 5. Review.

PMID:
22959308
7.

Zfp296 is a novel, pluripotent-specific reprogramming factor.

Fischedick G, Klein DC, Wu G, Esch D, Höing S, Han DW, Reinhardt P, Hergarten K, Tapia N, Schöler HR, Sterneckert JL.

PLoS One. 2012;7(4):e34645. doi: 10.1371/journal.pone.0034645. Epub 2012 Apr 2.

8.

Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.

Mosca E, Cocola C, Sabour D, Pelucchi P, Bertalot G, Palumbo O, Carella M, Götte M, Schöler HR, Reinbold R, Zucchi I, Milanesi L.

In Silico Biol. 2010;10(5-6):207-21. doi: 10.3233/ISB-2010-0437.

PMID:
22430355
9.

Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells.

Sommer CA, Christodoulou C, Gianotti-Sommer A, Shen SS, Sailaja BS, Hezroni H, Spira A, Meshorer E, Kotton DN, Mostoslavsky G.

PLoS One. 2012;7(12):e51711. doi: 10.1371/journal.pone.0051711. Epub 2012 Dec 14.

10.

Induced pluripotent stem cells (iPSCs)--a new era of reprogramming.

Kang L, Kou Z, Zhang Y, Gao S.

J Genet Genomics. 2010 Jul;37(7):415-21. doi: 10.1016/S1673-8527(09)60060-6.

PMID:
20659705
11.

Self-organizing map of gene regulatory networks for cell phenotypes during reprogramming.

Zhang L, Zheng Y, Li D, Zhong Y.

Comput Biol Chem. 2011 Aug 10;35(4):211-7. doi: 10.1016/j.compbiolchem.2011.05.002. Epub 2011 May 26.

PMID:
21864790
12.

Generation of rabbit pluripotent stem cell lines.

Tancos Z, Nemes C, Polgar Z, Gocza E, Daniel N, Stout TA, Maraghechi P, Pirity MK, Osteil P, Tapponnier Y, Markossian S, Godet M, Afanassieff M, Bosze Z, Duranthon V, Savatier P, Dinnyes A.

Theriogenology. 2012 Nov;78(8):1774-86. doi: 10.1016/j.theriogenology.2012.06.017. Epub 2012 Aug 24. Review.

PMID:
22925641
13.

Defining pluripotent stem cells through quantitative proteomic analysis.

Reiland S, Salekdeh GH, Krijgsveld J.

Expert Rev Proteomics. 2011 Feb;8(1):29-42. doi: 10.1586/epr.10.100. Review.

PMID:
21329426
14.

Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature.

Quattrocelli M, Thorrez L, Sampaolesi M.

Recent Pat Drug Deliv Formul. 2013 Apr;7(1):18-28. Review.

PMID:
22974171
15.

Nucleosome organizations in induced pluripotent stem cells reprogrammed from somatic cells belonging to three different germ layers.

Tao Y, Zheng W, Jiang Y, Ding G, Hou X, Tang Y, Li Y, Gao S, Chang G, Zhang X, Liu W, Kou X, Wang H, Jiang C, Gao S.

BMC Biol. 2014 Dec 21;12:109. doi: 10.1186/s12915-014-0109-x.

16.

Generation of transgene-free mouse induced pluripotent stem cells using an excisable lentiviral system.

Varga E, Nemes C, Davis RP, Ujhelly O, Klincumhom N, Polgar Z, Muenthaisong S, Pirity MK, Dinnyes A.

Exp Cell Res. 2014 Apr 1;322(2):335-44. doi: 10.1016/j.yexcr.2014.02.006. Epub 2014 Feb 18.

PMID:
24560743
17.

Returning to the stem state: epigenetics of recapitulating pre-differentiation chromatin structure.

Shafa M, Krawetz R, Rancourt DE.

Bioessays. 2010 Sep;32(9):791-9. doi: 10.1002/bies.201000033. Review.

PMID:
20652894
18.

Mitochondrial and metabolic remodeling during reprogramming and differentiation of the reprogrammed cells.

Choi HW, Kim JH, Chung MK, Hong YJ, Jang HS, Seo BJ, Jung TH, Kim JS, Chung HM, Byun SJ, Han SG, Seo HG, Do JT.

Stem Cells Dev. 2015 Jun 1;24(11):1366-73. doi: 10.1089/scd.2014.0561. Epub 2015 Apr 2.

PMID:
25590788
19.

Differentiation efficiency of induced pluripotent stem cells depends on the number of reprogramming factors.

Löhle M, Hermann A, Glass H, Kempe A, Schwarz SC, Kim JB, Poulet C, Ravens U, Schwarz J, Schöler HR, Storch A.

Stem Cells. 2012 Mar;30(3):570-9. doi: 10.1002/stem.1016.

20.

Estimating the quality of reprogrammed cells using ES cell differentiation expression patterns.

Zhang B, Chen B, Wu T, Tan Y, Qiu S, Xuan Z, Zhu X, Chen R.

PLoS One. 2011 Jan 11;6(1):e15336. doi: 10.1371/journal.pone.0015336.

Supplemental Content

Support Center